Literature DB >> 7742215

Spondyloepiphyseal dysplasia tarda and nephrotic syndrome in three siblings.

G Lama1, N Marrone, M Majorana, F Cirillo, M E Salsano, M M Rinaldi.   

Abstract

The association of a spondyloepiphyseal dysplasia tarda (SED-T) with the nephrotic syndrome (NS) was found in three siblings. They have counsaguineous (first cousins) healthy parents. Patient 1 was a boy who was admitted to hospital for oedema at the age of 8 years; NS was diagnosed, renal biopsy revealed mesangioproliferative glomerulonephritis. After 4 years he developed end-stage renal failure and died whilst on haemodialysis. Combined therapy with cyclophosphamide and prednisone was of no benefit. At the age of 11 years his height was 122 cm (< 3rd percentile -3.2 SD); he had a short neck, broad and prominent chest and a short wide trunk. Patient 2, another male, had non-nephrotic proteinuria in a 24-h urinary sample at the age of 11 years; this was confirmed in a later analysis; mild lymphopenia and a reduction of helper T cell (OKT4)/suppressor T cell (OKT8) ratio was also detected. At 22 years of age he was admitted to hospital with end-stage renal failure. He was on haemodialysis for a few months until his mother donated a kidney. At the age of 22 years his height was 157 cm (< 3rd percentile), he had a short trunk with the thoracic cage increased in anteroposterior diameter and shoulder elevation. Roentgenograms revealed a disostosis of the spinal column and pelvis and a slight lombar platyspondylia. Patient 3, a girl, was admitted to hospital at 12.5 years for pain and restricted mobility of the right hip. X-rays showed deep acetabula and short femoral necks and mild dysplastic changes, especially in the right hip.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7742215     DOI: 10.1007/BF00858959

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  13 in total

1.  [Not Available].

Authors:  P MAROTEAUX; M LAMY; J BERNARD
Journal:  Presse Med       Date:  1957-06-26       Impact factor: 1.228

2.  Schimke immuno-osseous dysplasia: a newly recognized multisystem disease.

Authors:  J Spranger; G K Hinkel; H Stöss; W Thoenes; D Wargowski; F Zepp
Journal:  J Pediatr       Date:  1991-07       Impact factor: 4.406

3.  Chondroitin-6-sulfate mucopoly-saccharidosis in conjunction with lymphopenia, defective cellular immunity and the nephrotic syndrome.

Authors:  R N Schimke; W A Horton; C R King; N L Martin
Journal:  Birth Defects Orig Artic Ser       Date:  1974

4.  Association of spondylo-epiphyseal dysplasia with nephrotic syndrome.

Authors:  J H Ehrich; G Offner; E Schirg; P F Hoyer; U Helmchen; J Brodehl
Journal:  Pediatr Nephrol       Date:  1990-03       Impact factor: 3.714

5.  The familial nephrotic syndrome. II. A clinicopathological study.

Authors:  M W Moncrieff; R H White; E F Glasgow; M H Winterborn; J S Cameron; C S Ogg
Journal:  Clin Nephrol       Date:  1973 Jul-Aug       Impact factor: 0.975

6.  Identification of the molecular defect in a family with spondyloepiphyseal dysplasia.

Authors:  B Lee; H Vissing; F Ramirez; D Rogers; D Rimoin
Journal:  Science       Date:  1989-05-26       Impact factor: 47.728

7.  Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation.

Authors:  S W Zimmerman
Journal:  Clin Nephrol       Date:  1984-07       Impact factor: 0.975

8.  Spondyloepiphyseal dysplasia tarda with progressive arthropathy.

Authors:  S A Al-Awadi; T I Fårag; K Naguib; M Y El-Khalifa; A Cuschieri; G Hosny; M Zahran; A G Al-Ansari
Journal:  J Med Genet       Date:  1984-06       Impact factor: 6.318

9.  Spondyloepiphyseal dysplasia tarda: a new autosomal recessive variant with mental retardation.

Authors:  G Kohn; E R Elrayyes; I Makadmah; A Rösler; M Grünebaum
Journal:  J Med Genet       Date:  1987-06       Impact factor: 6.318

10.  Spondyloepiphyseal dysplasia with nephrotic syndrome (Schimke immunoosseous dysplasia).

Authors:  A Santavá; J Zapletalová; K Michálková; S Hanáková; F Kopriva; J Santavý; J Dusek; D Kleinová
Journal:  Am J Med Genet       Date:  1994-02-01
View more
  5 in total

1.  Membranous nephropathy in Schimke immuno-osseous dysplasia.

Authors:  Nihal Ozdemir; Harika Alpay; Abdullah Bereket; Gamze Bereket; Neşe Biyikli; Metin Aydoğan; Fulya Cakalağoğlu; Işin Kiliçaslan; Ihsan Akpinar
Journal:  Pediatr Nephrol       Date:  2006-03-29       Impact factor: 3.714

2.  Chromatin changes in SMARCAL1 deficiency: A hypothesis for the gene expression alterations of Schimke immuno-osseous dysplasia.

Authors:  Marie Morimoto; Kunho Choi; Cornelius F Boerkoel; Kyoung Sang Cho
Journal:  Nucleus       Date:  2016-11       Impact factor: 4.197

3.  Schimke immuno-osseous dysplasia: a clinicopathological correlation.

Authors:  J Marietta Clewing; Barbara C Antalfy; Thomas Lücke; Behzad Najafian; Katja M Marwedel; Akira Hori; Ralph M Powel; A F Safo Do; Lydia Najera; Karen SantaCruz; M John Hicks; Dawna L Armstrong; Corndins F Boerkoel
Journal:  J Med Genet       Date:  2006-07-13       Impact factor: 6.318

4.  R561C missense mutation in the SMARCAL1 gene associated with mild Schimke immuno-osseous dysplasia.

Authors:  Arend Bökenkamp; Miranda deJong; Joanna A E van Wijk; Diana Block; Johanna M van Hagen; Michael Ludwig
Journal:  Pediatr Nephrol       Date:  2005-10-20       Impact factor: 3.714

5.  Schimke immunoosseous dysplasia: defining skeletal features.

Authors:  Kshamta B Hunter; Thomas Lücke; Jürgen Spranger; Sarah F Smithson; Harika Alpay; Jean-Luc André; Yumi Asakura; Radovan Bogdanovic; Dominique Bonneau; Robyn Cairns; Karlien Cransberg; Stefan Fründ; Helen Fryssira; David Goodman; Knut Helmke; Barbara Hinkelmann; Guiliana Lama; Petra Lamfers; Chantal Loirat; Silvia Majore; Christy Mayfield; Bertram F Pontz; Cristina Rusu; Jorge M Saraiva; Beate Schmidt; Lawrence Shoemaker; Sabine Sigaudy; Natasa Stajic; Doris Taha; Cornelius F Boerkoel
Journal:  Eur J Pediatr       Date:  2009-12-15       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.